BioVaxys Technology Statistics

Total Valuation

CSE:BIOV has a market cap or net worth of CAD 11.74 million. The enterprise value is 11.65 million.

Market Cap	11.74M
Enterprise Value	11.65M

Important Dates

The last earnings date was Friday, April 4, 2025.

Earnings Date	Apr 4, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:BIOV has 293.43 million shares outstanding. The number of shares has increased by 58.48% in one year.

Current Share Class	n/a
Shares Outstanding	293.43M
Shares Change (YoY)	+58.48%
Shares Change (QoQ)	+8.11%
Owned by Insiders (%)	12.08%
Owned by Institutions (%)	n/a
Float	257.98M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-6.73
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.10
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.42

Current Ratio	0.42
Quick Ratio	0.21
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-177.53%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	224.70%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is -0.14, so CSE:BIOV's price volatility has been lower than the market average.

Beta (5Y)	-0.14
52-Week Price Change	-50.00%
50-Day Moving Average	0.05
200-Day Moving Average	0.06
Relative Strength Index (RSI)	42.32
Average Volume (20 Days)	256,559

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.92M
Pretax Income	-5.54M
Net Income	-5.54M
EBITDA	n/a
EBIT	-3.92M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 157,415 in cash and 67,720 in debt, giving a net cash position of 89,695 or 0.00 per share.

Cash & Cash Equivalents	157,415
Total Debt	67,720
Net Cash	89,695
Net Cash Per Share	0.00
Equity (Book Value)	-1.74M
Book Value Per Share	-0.01
Working Capital	-1.74M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.76M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:BIOV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-58.48%
Shareholder Yield	-58.48%
Earnings Yield	-47.23%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a